Primary |
Product Used For Unknown Indication |
66.3% |
Hypertension |
8.6% |
Drug Use For Unknown Indication |
4.6% |
Drug Use For Unknown Indication |
4.6% |
Blood Pressure High |
2.3% |
Acute Promyelocytic Leukemia |
1.7% |
Arrhythmia |
1.7% |
Cardiac Failure |
1.7% |
Depression |
1.1% |
High Cholesterol |
1.1% |
Liver Transplant |
1.1% |
Cardiac Disorder |
0.6% |
Anticoagulant Therapy |
0.6% |
Anxiety |
0.6% |
Blood Pressure |
0.6% |
Breast Cancer |
0.6% |
Cardiac Disorder |
0.6% |
Coronary Artery Disease |
0.6% |
Diabetes Mellitus |
0.6% |
Flushing |
0.6% |
|
Toxicity To Various Agents |
41.5% |
Weight Increased |
7.3% |
Neoplasm Malignant |
4.9% |
Renal Aplasia |
4.9% |
Respiratory Arrest |
4.9% |
Blood Pressure Decreased |
2.4% |
Blood Pressure Increased |
2.4% |
Cerebrovascular Accident |
2.4% |
Completed Suicide |
2.4% |
Exposure During Pregnancy |
2.4% |
Hypotension |
2.4% |
Infarction |
2.4% |
Lung Transplant |
2.4% |
Mania |
2.4% |
Meconium In Amniotic Fluid |
2.4% |
Medication Error |
2.4% |
Pain |
2.4% |
Potentiating Drug Interaction |
2.4% |
Premature Delivery |
2.4% |
Pulmonary Artery Stenosis Congenital |
2.4% |
|
Secondary |
Product Used For Unknown Indication |
40.0% |
Drug Use For Unknown Indication |
21.4% |
Hypertension |
11.9% |
Myocardial Ischaemia |
4.2% |
Type 2 Diabetes Mellitus |
3.2% |
Ill-defined Disorder |
2.8% |
Depression |
2.5% |
Drug Exposure During Pregnancy |
2.1% |
Atrial Fibrillation |
1.4% |
Blood Pressure |
1.4% |
Blood Pressure Increased |
1.4% |
Bipolar Disorder |
1.1% |
Dementia Alzheimer's Type |
1.1% |
Poisoning Deliberate |
1.1% |
Prophylaxis |
1.1% |
Angina Pectoris |
0.7% |
Arthritis Bacterial |
0.7% |
Cardiac Disorder |
0.7% |
Erectile Dysfunction |
0.7% |
Ischaemic Heart Disease Prophylaxis |
0.7% |
|
Toxicity To Various Agents |
25.0% |
Completed Suicide |
10.7% |
Convulsion |
5.4% |
Overdose |
5.4% |
Renal Failure Acute |
5.4% |
Splenomegaly |
5.4% |
Vomiting |
5.4% |
Drug Abuse |
3.6% |
Exposure Via Ingestion |
3.6% |
Myocardial Infarction |
3.6% |
Oedema Peripheral |
3.6% |
Respiratory Arrest |
3.6% |
Sinus Bradycardia |
3.6% |
Ventricular Fibrillation |
3.6% |
White Blood Cell Count Decreased |
3.6% |
Accidental Overdose |
1.8% |
Atrial Fibrillation |
1.8% |
Blood Glucose Fluctuation |
1.8% |
Blood Pressure Increased |
1.8% |
Death |
1.8% |
|
Concomitant |
Plasma Cell Myeloma |
12.8% |
Prophylaxis Against Transplant Rejection |
9.4% |
Product Used For Unknown Indication |
8.3% |
Hypertension |
6.2% |
Osteoporosis |
5.5% |
Type 2 Diabetes Mellitus |
5.3% |
Drug Use For Unknown Indication |
4.9% |
Multiple Sclerosis |
4.9% |
Myelodysplastic Syndrome |
4.7% |
Acute Myeloid Leukaemia |
4.5% |
Ill-defined Disorder |
4.5% |
Renal Transplant |
4.4% |
Chronic Myeloid Leukaemia |
3.7% |
Depression |
3.6% |
Non-small Cell Lung Cancer |
3.6% |
Blood Cholesterol Increased |
3.2% |
Diabetes Mellitus |
2.9% |
Multiple Myeloma |
2.9% |
Pain |
2.4% |
Nephrogenic Anaemia |
2.3% |
|
Vomiting |
14.4% |
Weight Decreased |
7.2% |
Pneumonia |
5.9% |
White Blood Cell Count Decreased |
5.9% |
Weight Increased |
5.5% |
Nausea |
5.1% |
Pseudomonas Infection |
5.1% |
Renal Failure |
4.7% |
Thrombocytopenia |
4.7% |
Pulmonary Embolism |
4.2% |
Unresponsive To Stimuli |
4.2% |
Drug Ineffective |
3.8% |
Platelet Count Decreased |
3.8% |
Pruritus |
3.8% |
Somnolence |
3.8% |
Tachycardia |
3.8% |
Vision Blurred |
3.8% |
Myocardial Infarction |
3.4% |
Pancreatitis |
3.4% |
Rash |
3.4% |
|